Shandong Juntai Pharmaceutical Co., Ltd.

Company Profile

Country: China (Mainland)

Business Type: Manufacturers

Diamond supplier:
cooperative member

1Year Product Certification&Enterprise Certification

Ms.Sophie Yang

Tel: --

Mobile:15098843573
Please mention that you found the contact information on LookChem.
Tel:--
Fax:
URL:http://www.h2opharm.com
Province/state:Shandong
City:Jinan
Street:No. 2566, Century Avenue Road,High tech Zone, Jinan city,Shandong Province, China
MaxCard:

About us

Welcome To Our Site!
Shandong Juntai Pharmaceutical Co., Ltd. is a high-tech, specialized and innovative enterprise integrating R&D, manufacturing and sales. We focus on providing high-quality pharmaceutical raw materials, advanced intermediates, peptide-related intermediates and cosmetic active ingredients for global customers.

Our main product portfolio includes intermediates for Semaglutide, Tirzepatide, Retatrutide, Liraglutide, Insulin Degludec and other pharmaceutical projects, as well as peptide modifiers, protected amino acids, long-chain dicarboxylic acid derivatives, Pro-Xylane and Ectoine. We also provide custom synthesis, process development and scale-up manufacturing services.

Juntai has established an approximately 1,500 m2 R&D center in Jinan High-tech Zone and has developed three core technical platforms: small-molecule chemistry, peptide modifiers and synthetic biology. The company operates three production bases located in Zaozhuang, Shanghe Provincial Chemical Park and Juancheng Chemical Park, enabling flexible support from laboratory development to commercial production.

Following the principle of “Quality by Design,” we emphasize high purity, controlled impurities, batch-to-batch consistency and reliable delivery. Our quality control capabilities include HPLC, GC, LC-MS and other analytical testing methods.

In 2020, Juntai expanded into the cosmetic ingredient sector and developed the KTcos? active ingredient portfolio. In 2023, KTcos? Pro-Xylane received the China Cosmetics Association Innovation Achievement Award and the First Prize of Science and Technology from the China General Chamber of Commerce. In March 2024, Juntai served as the chief editor of the group standard for Hydroxypropyl Tetrahydropyrantriol.

With stable product quality and responsive technical support, Juntai has established cooperation with well-known companies including Gilead, Qilu Pharmaceutical, Chia Tai Tianqing Pharmaceutical, United Laboratories, Huadong Medicine and Huahai Pharmaceutica
Process Capability : We have established three core technology platforms: small-molecule chemistry, peptide modifiers and synthetic biology. Our capabilities cover synthetic route development, process optimization, crystallization development, impurity control, pilot-scale production and commercial scale-up. HPLC, GC, LC-MS and other analytical methods are used for in-process control and final product testing.
After-sale Service : We provide responsive technical and documentation support throughout the cooperation process. COA and relevant product documents can be supplied according to customer requirements. Our team follows up on production, packaging and delivery progress, and provides timely support for technical questions, quality feedback and batch-related issues.